Colorado Drug Board Defends Pay Limits Against Amgen Lawsuit (1)

Colorado’s prescription drug review board has authority to limit what state-regulated health plans pay for certain drugs, the state attorney general’s office wrote Friday in its latest response to a lawsuit from Amgen Inc.

The work of the Colorado Prescription Drug Affordability Board “is a necessary, careful, and tailored exercise of the state’s police power to help alleviate the threat that unaffordability of prescription drugs poses to Coloradans,” attorneys in the office of Colorado Attorney General Philip J. Weiser argued on behalf of the board’s members in a combined cross-motion for summary judgment and a response in opposition to ...